AI-assisted 3d mammogram for breast diagnosis and treatment
Part of Cancer, Skin clinical trials.
This study is testing an artificial intelligence (AI) tool that reads 3D mammograms (called DBT) to help doctors find and manage breast conditions more accurately and quickly. It could help guide treatment, especially for women getting chemotherapy before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman age 18 or older.
- You need to have had a 3D mammogram of both breasts (called DBT) with two standard views from each side.
- Scientists need a tissue sample (from a biopsy or surgery) to confirm what your breast finding is, or a note that a benign finding has not changed for over 2 years.
- For a portion of the study, if you are being treated for breast cancer, you may have had chemotherapy before your surgery (called neoadjuvant therapy) and have results from that surgery.
- You cannot join if you have had prior breast surgery or radiation therapy (unless the study is looking at recurrence risk).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a newer, more detailed 3D mammogram (called wide-angle tomosynthesis) combined with artificial intelligence (AI) to help doctors see breast tissue more clearly. It might improve the accuracy of diagnosing breast conditions in people who have been called back for more imaging or have breast symptoms.
This study tests whether an artificial intelligence (AI) system can help a second reader interpret routine breast screening mammograms. It may improve how consistently images are assessed, especially when the first reader calls them normal or benign.
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
This study tests a new artificial intelligence (AI) tool that works with doctors to more accurately diagnose breast cancer that has a large area of early-stage cells (DCIS) mixed with invasive cancer. It may help improve treatment decisions for people with larger, calcified tumors.
This study uses artificial intelligence to look at chest CT scans taken during routine health check-ups to find early signs of breast cancer. It may help improve early detection without extra scans.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.